View report page

23
unconnected with the method of treatment. The early use of serum undoubtedly
seems to prevent cardiac damage.
(3) The older view that scarlet fever plays an important part in the production
of cardiac disorders requires some modification. The present type of scarlet fever
is admittedly of a comparatively benign nature ; but there are good grounds for
believing that, with an extension of serum therapy, cardiac complications, which
are other than rheumatic in origin, will become increasingly rare in scarlet fever.
I wish to acknowledge my indebtedness to Dr. G. W. Ronaldson, medical
superintendent of the South-Eastern hospital, for granting me the facilities to
undertake this investigation and for his suggestions in the preparation of this paper.
References.
Brelet, M. Medical Science, 1920, ii, p. 156.
Burnett, C. T. and Piltz, G. F. Journ. Amer. Med. Assocn., 1929, XCIII, pp. 1120-1126.
Cushing, R. W. Medical Officer, 1931, XLV, p. 263.
Duchosal, P. and Sciclounotf, F. Arch, du Mai. du Coeur, 1934, XXVII, pp. 109—416.
Faulkner, J. M., Place, E. H. and Ohler, W. R. Amer. Journ. Med. Sci., March 1935, p. 352.
Jamieson, R. A. Can. Med. Assocn. Journ., 1924, XIV, pp. 1087-1088.
Joe, A. Edinb. M. J., 1924, XXXI, pp. 341-349.
Place, E. H. New Eng. Journ. Med., 1932, CCVII, pp. 864-874.
Rosenbaum, H. A. Arch. Int. Med., 1920, ii, pp. 424—430.
Thomson, D. and Thomson, R. Ann. Pickett-Thomson Research Lab., 1930, VI, pp. 358-359.
Tournafond, P. These de Paris, 1933, No. 134.
Zischinsky, H. Jahrb. f. Kinderheilk., 1933, CXXVII, 337.